Back
66
Day Range
$1.47
$1.61
52-Week Range
$1.04
$2.01
Volume
19,570,526
50D / 200D Avg
$1.54
/
$1.38
Prev Close
$1.46
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -11.5 | 0.4 |
| P/B | 4.4 | 2.9 |
| ROE % | -33.9 | 3.8 |
| Net Margin % | -46.7 | 3.9 |
| Rev Growth 5Y % | 239.0 | 10.0 |
| D/E | 1.1 | 0.2 |
Key Takeaways
Revenue grew 238.96% annually over 5 years — strong growth
Negative free cash flow of -111.09M
PEG of 0.20 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 100.13%
Capital efficient — spends only 0.03% of revenue on capex
Growth
Revenue Growth (5Y)
238.96%
Revenue (1Y)138.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-33.89%
ROIC-8.46%
Net Margin-46.65%
Op. Margin-29.28%
Safety
Debt / Equity
1.11
Current Ratio4.66
Interest Coverage-1.65
Valuation
P/E Ratio
-11.50
P/B Ratio4.37
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 138.83% | Revenue Growth (3Y) | 2685.44% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 238.96% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 183.88M | Net Income (TTM) | -85.78M |
| ROE | -33.89% | ROA | -15.04% |
| Gross Margin | 97.42% | Operating Margin | -29.28% |
| Net Margin | -46.65% | Free Cash Flow (TTM) | -111.09M |
| ROIC | -8.46% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.11 | Current Ratio | 4.66 |
| Interest Coverage | -1.65 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.50 | P/B Ratio | 4.37 |
| P/S Ratio | 5.36 | PEG Ratio | 0.20 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 986.44M | Enterprise Value | 1.16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 183.88M | 76.99M | 237,000.0 | 596,000.0 | 1.39M |
| Net Income | -85.78M | -174.57M | -184.13M | -141.90M | -116.11M |
| EPS (Diluted) | -0.13 | -0.27 | -0.32 | -0.37 | -0.37 |
| Gross Profit | 179.14M | 75.74M | 237,000.0 | 596,000.0 | 1.39M |
| Operating Income | -53.84M | -173.73M | -193.94M | -138.55M | -114.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 570.54M | 593.78M | 394.08M | 190.58M | 226.03M |
| Total Liabilities | 344.67M | 313.46M | 146.13M | 110.58M | 99.62M |
| Shareholders' Equity | 225.87M | 280.32M | 247.95M | 80.00M | 126.42M |
| Total Debt | 251.57M | 121.72M | 85.90M | 55.75M | 55.00M |
| Cash & Equivalents | 79.44M | 79.02M | 70.02M | 56.85M | 34.87M |
| Current Assets | 520.27M | 490.99M | 341.35M | 180.25M | 187.21M |
| Current Liabilities | 111.54M | 88.30M | 108.07M | 76.69M | 45.52M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#19 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026